After obesity drugs’ success, companies rush to preserve skeletal muscle

After obesity drugs’ success, companies rush to preserve skeletal muscle

A growing number of companies are testing muscle-building agents to counter the side effects of dramatic weight loss and potentially to preserve lean muscle into old age.

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

24,99 € / 30 days

cancel any time

Subscribe to this journal

Receive 12 print issues and online access

209,00 € per year

only 17,42 € per issue

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Log in

Learn about institutional subscriptions

Read our FAQs

Contact customer support

Author information

Authors and Affiliations

Richmond, VA, USA

Carrie Arnold

About this article

Cite this article

Arnold, C. After obesity drugs’ success, companies rush to preserve skeletal muscle.
Nat Biotechnol (2024). https://doi.org/10.1038/s41587-024-02176-5

Download citation

Published: 05 March 2024

DOI: https://doi.org/10.1038/s41587-024-02176-5

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Nature.com – https://www.nature.com/articles/s41587-024-02176-5

Exit mobile version